Relpax and Revlimid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Relpax (eletriptan hydrobromide) and Revlimid (lenalidomide). Common drug interactions include feeling of body temperature change among females and deep vein thrombosis among males.

The phase IV clinical study analyzes what interactions people have when they take Relpax and Revlimid. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.

What is Relpax?

Relpax has active ingredients of eletriptan hydrobromide. It is often used in migraine. eHealthMe is studying from 9,259 Relpax users. Check the latest studies of Relpax.

What is Revlimid?

Revlimid has active ingredients of lenalidomide. It is often used in multiple myeloma. eHealthMe is studying from 378,026 Revlimid users. Check the latest studies of Revlimid.



On Aug, 12, 2026

37 people who take Relpax and Revlimid together, and have interactions are studied.

Relpax and Revlimid drug interactions.

What are the common drug interactions of Relpax and Revlimid, by gender? *:

female:

  1. Feeling of body temperature change
  2. Headache (pain in head)
  3. Muscle spasms (muscle contraction)
  4. Myalgia (muscle pain)
  5. Nausea (feeling of having an urge to vomit)
  6. Neuropathy peripheral (surface nerve damage)
  7. Diarrhoea
  8. Infection
  9. Dry eye (lack of adequate tears)
  10. Drug ineffective

male:

  1. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  2. Rash
  3. Anxiety
  4. Diarrhoea
  5. Headache (pain in head)
  6. Hypersensitivity
  7. Neuropathy peripheral (surface nerve damage)
  8. Thrombosis (formation of a blood clot inside a blood vessel)
  9. Urticaria (rash of round, red welts on the skin that itch intensely)

What are the common drug interactions of Relpax and Revlimid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Weight increased

40-49:

n/a

50-59:

  1. Diarrhoea
  2. Herpes zoster
  3. Ear pain
  4. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  5. Neck pain
  6. Respiratory tract infection
  7. Bone pain
  8. Neutropenia (an abnormally low number of neutrophils)
  9. White blood cell count decreased
  10. Cardiac arrest

60+:

  1. Arthralgia (joint pain)
  2. Feeling of body temperature change
  3. Eye pain
  4. Eyelid pain
  5. Lacrimation increased
  6. Photophobia (extreme sensitivity to light)
  7. Neurotrophic keratopathy (decreased corneal sensitivity and poor corneal healing)
  8. Rash
  9. Disease recurrence
  10. Abdominal pain upper

What are the existing conditions these people have? *

  1. Pain: 3 people, 8.11%
  2. Neurotrophic Keratopathy (decreased corneal sensitivity and poor corneal healing): 3 people, 8.11%
  3. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 5.41%
  4. Nausea (feeling of having an urge to vomit): 2 people, 5.41%
  5. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 5.41%
  6. Hypoaesthesia Eye (reduced sense of touch or sensation on eyes): 2 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Do you take Relpax and Revlimid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Relpax and Revlimid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Relpax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Revlimid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Relpax and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Revlimid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on eletriptan hydrobromide and lenalidomide (the active ingredients of Relpax and Revlimid, respectively), and Relpax and Revlimid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: